L

Lotus Pharmaceutical
1795

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NT$57.19B
EV
NT$63.99B
Shares Outstanding
261.75M
Beta
-0.02

Wall Street View

Analyst Rating
BUY
Analyst Target Price
NT$357.00
P/E 2025E
10.44x
P/Revenue 2025E
2.84x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lotus Pharmaceutical Co., Ltd.

gainify

L

Lotus Pharmaceutical Co., Ltd.

1795

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardio...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Vazharov, Petar

Employees

1,099

IPO Date

2007-12-21

Headquarters

No. 277 Song Ren Road, 17th Floor, Xin Yi District, Taipei 110, Taiwan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.